ORAL INTAKE OF LOADING DOSES OF ANTIARRHYTHMIC DRUGS FOR SINUS RHYTHM RESTORATION IN ATRIAL FIBRILLATION

ORAL INTAKE OF LOADING DOSES OF ANTIARRHYTHMIC DRUGS FOR SINUS RHYTHM RESTORATION IN ATRIAL FIBRILLATION

Oral intake of loading doses of antiarrhythmic drugs for sinus rhythm restoration in atrial fibrillation.

Saved in:

Bibliographic Details
Main Authors:	E. O. Khamitsayeva, P. K. Janashya, E. Y. Bogdanova, N. M. Shevchenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1755
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Heart rate variability in patients with atrial fibrillation of sinus rhythm or atrial fibrillation: chaos or merit?
by: Lifan Zhang, et al.
Published: (2025-12-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

Clinical Efficacy of Canrenone in Restoring Sinus Rhythm in Patients With Atrial Fibrillation—A Pilot, Randomized, Double-Blind Study
by: Rafał Dąbrowski MD, PhD, et al.
Published: (2025-07-01)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
by: Mathijs S van Schie, et al.
Published: (2022-07-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Inter-subject variability in human atrial action potential in sinus rhythm versus chronic atrial fibrillation.
by: Carlos Sánchez, et al.
Published: (2014-01-01)

Stroke volume estimation by rheo-echocardiography during atrial fibrillation converted to sinus rhythm
by: Tadeusz PAŁKO, et al.
Published: (2015-07-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Surgical approaches to maintaining sinus rhythm in patients with type 2 diabetes and long-term persistent atrial fibrillation
by: I. A. Khamnagadaev, et al.
Published: (2025-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: O. N. Miller, et al.
Published: (2011-08-01)

Three-Dimensional Left Atrial Reservoir Function During Sinus Rhythm Can Discriminate Between a History of Paroxysmal Atrial Fibrillation and its Absence
by: Jiří Plášek, et al.
Published: (2025-06-01)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
by: William Eysenck, et al.
Published: (2020-11-01)

Catheter ablation of atrial fibrillation versus antiarrhythmic therapy in patients with left ventricular systolic dysfunction
by: D. F. Ardus, et al.
Published: (2023-05-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy
by: Jaejin An, PhD, et al.
Published: (2025-05-01)

Prediction of sinus rhythm maintenance after radiofrequency ablation in patients with atrial fibrillation using speckle tracking echocardiography and dynamics of left atrial structural and functional parameters
by: T. I. Musin, et al.
Published: (2021-07-01)

SINUS NODE DYSFUNCTIONS AND FEATURES OF NORMAL RHYTHM RESTORATION AFTER HEART TRANSPLANTATION
by: S.Y. Shemakin
Published: (2009-05-01)

Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey
by: Espen Fengsrud, et al.
Published: (2025-08-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
by: Yaariv Khaykin, et al.
Published: (2016-10-01)

Mechanisms of paroxysmal atrial fibrillation in patients with sick sinus syndrome
by: S. Yu. Ivanov, et al.
Published: (2004-08-01)

Rhythmocardiography in the analysis of sinus rhythm wave variability
by: T. F. Mironova, et al.
Published: (2007-10-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

INFLUENCE OF AEROBIC AND RESISTANT LOAD ON THE RISK OF ATRIAL FIBRILLATION IN ARTERIAL HYPERTENSION AND PAROXYSMAL ATRIAL FIBRILLATION
by: K. G. Adamyan, et al.
Published: (2015-10-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management
by: Szymon Pucyło, et al.
Published: (2025-06-01)

Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study
by: Seokmoon Han, et al.
Published: (2025-07-01)